Cytek Biosciences, Inc.CTKBNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank17
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P17
Within normal range
vs 5Y Ago
-0.7x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-140.13%
20244713.66%
2023102.05%
2022-8407.89%
2021-98.05%
2020192.45%
20190.00%